Structures by: Lavergne J. P.
Total: 18
C33H38N4O2
C33H38N4O2
New Journal of Chemistry (2001)
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C33H38N4O2
C33H38N4O2
New Journal of Chemistry (2001) 25, 12 1479-1481
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C19H18Cl1N3O1
C19H18Cl1N3O1
Acta Crystallographica Section E (2003) 59, 2 o143-o144
a=9.2793(2)Å b=9.4256(2)Å c=20.6390(8)Å
α=84.7130(10)° β=80.5830(10)° γ=69.2100(10)°
Ethyl 3-(4-chlorophényl)-3a-méthyl- 5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] triazolo [4,3-a] [1,5] benzodiazépine
C26H23ClN4O2
Acta Crystallographica Section C (1995) 51, 5 961-963
a=10.207(8)Å b=26.978(12)Å c=8.744(6)Å
α=90.00° β=106.96(3)° γ=90.00°
C27H32N4O2
C27H32N4O2
Acta Crystallographica Section C (1996) 52, 3 736-739
a=10.169(3)Å b=8.748(2)Å c=15.254(5)Å
α=104.45(5)° β=97.40(5)° γ=109.22(5)°
C28H34N4O2
C28H34N4O2
Acta Crystallographica Section C (1996) 52, 3 736-739
a=9.894(3)Å b=9.908(3)Å c=14.780(5)Å
α=105.29(5)° β=94.07(5)° γ=112.20(5)°
(3R),(2S)-2'-N-Dibenzylamino-1,2:5,6-diisopropylidène-α-D-allofuranos-3- spiro-β-propiolactone
C28H33NO7
Acta Crystallographica Section C (1997) 53, 4 457-459
a=32.156(13)Å b=7.114(2)Å c=12.118(6)Å
α=90.00° β=101.47(6)° γ=90.00°
L-2-(1,2:5,6-di-O-isopropylidène-α-D-allofuranos-3-yl) dibenzyl-tert- butyle glycinate
C32H43NO8
Acta Crystallographica Section C (1994) 50, 1 110-112
a=13.679(4)Å b=15.182(4)Å c=15.390(3)Å
α=90.00° β=90.00° γ=90.00°
1-mésityl-3a-méthyl-5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] oxadiazolo [4,5-a] [1,5] benzodiazépine
C26H25N3O
Acta Crystallographica Section C (1995) 51, 9 1898-1900
a=8.521(3)Å b=15.367(6)Å c=16.892(6)Å
α=90.00° β=90.00° γ=90.00°
2α, 3α,-7α, 13α-diépoxyhimachalane
C15H24O2
Acta Crystallographica Section C (1992) 48, 9 1720-1722
a=6.548(2)Å b=9.685(2)Å c=21.282(8)Å
α=90.00° β=90.00° γ=90.00°
(2S,3R)-2-amino-3-hydroxyl-3-(1,2:3,4-di-o-isopropylidène- α-D-galactopyranos-5-yl) propanoate de méthyle
C15H25NO8
Acta Crystallographica Section C (1993) 49, 4 828-830
a=5.648(2)Å b=26.369(8)Å c=11.868(4)Å
α=90.00° β=90.19(2)° γ=90.00°
?
C27H28Cl2N6O4
Acta Crystallographica Section C (1996) 52, 12 3213-3215
a=9.841(1)Å b=21.845(2)Å c=13.015(3)Å
α=90.0(2)° β=94.43(5)° γ=90.0(3)°
?
C27H24Cl2N4O2S1
Acta Crystallographica Section C (1998) 54, 9 1343-1345
a=8.1100(10)Å b=10.045(2)Å c=30.670(3)Å
α=90.0° β=90.8(3)° γ=90.0°
1,7-diéthoxycarbonyl-3a-méthyl-4a-phényl- 3,5-diparanitrophényl-3a,4,4a,5-tétrahydro-3H-bis[1,2,4] triazolo[4,3-a:3,4'-d][1,5]benzodiazépine
C36H32N8O8,C1H1Cl3
Acta Crystallographica Section C (1995) 51, 7 1352-1355
a=12.044(7)Å b=12.461(7)Å c=13.730(8)Å
α=104.33(3)° β=94.47(3)° γ=101.00(3)°
(1R,2R,5(1)S,9R,2'R,4'R,5'S)-2,10,10- triméthyl-3-oxa-6-azatricyclo[7.1.1.0^2,7^]undeca-5-spiro[1'(2',4',5'- triméthylcyclohexane)]-6-ène-4-one
C20H31NO2
Acta Crystallographica Section C (1994) 50, 7 1122-1124
a=6.241(6)Å b=7.319(7)Å c=10.505(15)Å
α=84.65(3)° β=94.83(2)° γ=100.80(3)°
Dimethyl 3-benzyl-2-(4-methyl-2,5-dioxoimidazolidin-1-yl)butanedioate
C17H20N2O6
Acta Crystallographica Section C (2001) 57, 1 62-63
a=11.0323(7)Å b=11.7742(4)Å c=14.1121(9)Å
α=90° β=99.380(2)° γ=90°
C33H38N4O2
C33H38N4O2
Acta Crystallographica Section C (2000) 56, 1 e25-e26
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C24H25ClN2O6
C24H25ClN2O6
Acta Crystallographica Section C (2000) 56, 10 e461-e462
a=9.9783(3)Å b=20.4064(7)Å c=11.1476(3)Å
α=90.000(10)° β=93.231(2)° γ=90.000(10)°